Deciphera Pharmaceuticals CEO Michael Taylor's 2018 pay jumps 216% to $5.2M
Deciphera Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 22, 2019
Deciphera Pharmaceuticals reported fiscal year 2018 executive compensation information on April 22, 2019.
In 2018, three executives at Deciphera Pharmaceuticals received on average a compensation package of $3.6M, a 171% increase compared to previous year.
Average pay of disclosed executives at Deciphera Pharmaceuticals
Michael D. Taylor, Chief Executive Officer, received $5.2M in total, which increased by 216% compared to 2017. 84% of Taylor's compensation, or $4.4M, was in option awards. Taylor also received $322K in non-equity incentive plan, $515K in salary, as well as $11K in other compensation.
Daniel C. Martin, Chief Commercial Officer, received a compensation package of $3.2M. 69% of the compensation package, or $2.2M, was in option awards.
Thomas P. Kelly, Chief Financial Officer, earned $2.3M in 2018.
Related executives
You may also like
Source: SEC filing on April 22, 2019.